126 related articles for article (PubMed ID: 37563840)
1. Forensic sequencing of Salmonella cultured from hematopoietic progenitor cell products collected by apheresis from two asymptomatic donors.
Koepsell S
Transfusion; 2023 Aug; 63(8):1615-1617. PubMed ID: 37563840
[No Abstract] [Full Text] [Related]
2. Comparison between peripheral blood progenitor cell collection on the 4
Passeri C; Iuliani O; Di Ianni M; Sorrentino C; Giancola R; Abbruzzese L; Dallavalle FM; Gattillo S; Mariano MT; Martino M; Ostuni A; Savignano C; Santoleri L; Tison T; Vacca M; Accorsi P
Blood Transfus; 2023 Jan; 21(1):37-41. PubMed ID: 35969140
[No Abstract] [Full Text] [Related]
3. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
4. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
Engelhardt M; Bertz H; Wäsch R; Finke J
Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
[TBL] [Abstract][Full Text] [Related]
5. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
7. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
8. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.
Lane TA; Law P; Maruyama M; Young D; Burgess J; Mullen M; Mealiffe M; Terstappen LW; Hardwick A; Moubayed M
Blood; 1995 Jan; 85(1):275-82. PubMed ID: 7528570
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience.
Uzoka C; Liu LC; Park Y; Lin Y; Patel P; Campbell-Lee S; Sweiss K; Wang X; Tepak E; Peace D; Saraf S; Rondelli D; Mahmud N
J Clin Apher; 2021 Aug; 36(4):634-644. PubMed ID: 34046928
[TBL] [Abstract][Full Text] [Related]
10. Updates on the mobilization pipeline for hematopoietic stem cell collection.
Tran MH; Yunce M
J Clin Apher; 2023 Dec; 38(6):738-745. PubMed ID: 37746743
[TBL] [Abstract][Full Text] [Related]
11. Plerixafor added to G-CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR-alpha/beta depletion in pediatric haploidentical and genoidentical donors failing to mobilize with G-CSF alone.
Kurnikova E; Trakhtman P; Pershin D; Ilyushina M; Khismatullina R; Maschan M; Novichkova G; Maschan A
J Clin Apher; 2021 Aug; 36(4):547-552. PubMed ID: 33682959
[TBL] [Abstract][Full Text] [Related]
12. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency.
Tichelli A; Passweg J; Hoffmann T; Gregor M; Kühne T; Favre G; Wodnar-Filipowicz A; Gratwohl A
Br J Haematol; 1999 Jul; 106(1):152-8. PubMed ID: 10444178
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections.
Gambell P; Herbert K; Dickinson M; Stokes K; Bressel M; Wall D; Harrison S; Prince HM
Biol Blood Marrow Transplant; 2012 May; 18(5):763-72. PubMed ID: 22227589
[TBL] [Abstract][Full Text] [Related]
14. Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant.
Jaime-Pérez JC; Gómez-Galaviz AC; Turrubiates-Hernández GA; Picón-Galindo E; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
Cytotherapy; 2020 Mar; 22(3):144-148. PubMed ID: 32057615
[TBL] [Abstract][Full Text] [Related]
15. Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatment.
Liwski CJ; Padley DJ; Gustafson MP; Winters JL; Gastineau DA; Jacob EK
Transfusion; 2014 Mar; 54(3):541-4. PubMed ID: 23808629
[TBL] [Abstract][Full Text] [Related]
16. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic progenitor cell mobilization using low-dose cyclophosphamide and granulocyte colony-stimulating factor for multiple myeloma.
Shimura Y; Kuroda J; Uchiyama H; Kawata-Iida E; Tsutsumi Y; Nagoshi H; Mizutani S; Yamamoto-Sugitani M; Matsumoto Y; Kobayashi T; Horiike S; Shimazaki C; Kaneko H; Kobayashi Y; Taniwaki M
J Clin Apher; 2013 Oct; 28(5):368-73. PubMed ID: 23804501
[TBL] [Abstract][Full Text] [Related]
18. Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cells.
Maziarz RT; Nademanee AP; Micallef IN; Stiff PJ; Calandra G; Angell J; Dipersio JF; Bolwell BJ
Biol Blood Marrow Transplant; 2013 Apr; 19(4):670-5. PubMed ID: 23333777
[TBL] [Abstract][Full Text] [Related]
19. Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation.
Okamoto Y; Watanabe T; Watanabe H; Onishi T; Kawano Y
Pediatr Transplant; 2009 Jun; 13(4):440-3. PubMed ID: 18992065
[TBL] [Abstract][Full Text] [Related]
20. Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.
Vogel W; Kunert C; Blumenstengel K; Fricke HJ; Kath R; Sayer HG; Höffken K
J Cancer Res Clin Oncol; 1998; 124(6):341-5. PubMed ID: 9692843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
